Detailed Narrative
Robust Financial Performance in FY25
Jeena Sikho Lifecare demonstrated strong financial growth in FY25. The company reported a 45% YoY increase in full-year revenue to INR 469 crores, with H2 FY25 revenue growing 53% YoY to INR 255 crores. EBITDA for FY25 stood at INR 124.88 crores, up 34% YoY, maintaining a healthy 27% margin. Net profit for the full year reached INR 90.73 crores, reflecting a 31% YoY growth. The company also highlighted a strong balance sheet with INR 26 crores in net cash equivalent, and achieved an ROE of 39% and ROCE of 63%.
Aggressive Bed Capacity Expansion and Occupancy Management
The company significantly expanded its bed capacity, adding 573 beds in H2 FY25 to reach a total of 2173 beds by March 31, 2025, up from 1277 in FY24. However, only 1600 of these beds were operational due to pending regulatory approvals, resulting in an overall occupancy rate of 53% for FY25. Management aims to improve occupancy to 70-80% in FY26 and targets 2800 beds by the end of FY26, with a long-term vision of 10,000 beds within the next five years.
Strategic Shift to Asset-Light Expansion Model
Jeena Sikho is implementing a new business model focused on tying up with Ayurvedic colleges to expand bed capacity without incurring significant capital expenditure. This strategy is expected to add approximately 300 beds within 3-6 months from initial agreements with Saraswati College and Sanskriti University. This approach leverages existing college infrastructure and staff, allowing the company to offer services at a lower price point (INR 6,000-7,000 per day) compared to its own hospitals (INR 9,000-10,000 per day), thereby enhancing ROI and market reach.
Service Vertical Drives Growth; Product Innovation and OTC Launch Planned
The service vertical was the primary growth engine, with revenue soaring 84% YoY to INR 254 crores in FY25, while the product vertical grew 16% to INR 215 crores. Management emphasized the higher margins and faster patient recovery in services. The company is also preparing to launch 10-15 new OTC products in the next 2-3 months, adopting a 'kit' model for products like Pet Saffa. The recently launched INJK Water device has already achieved sales of INR 1.5 crores per month, indicating strong product traction.
Managing Government Receivables and International Expansion
The company reported INR 82 crores in government receivables as of March 31, 2025, acknowledging a 3-6 month payment cycle. Management has taken proactive steps to reduce dependency on government business, including demanding prior payments and temporarily halting admissions for non-payment, expecting maximum recovery within 3-6 months. Concurrently, Jeena Sikho is pursuing international expansion, with one center already operational in Dubai and plans to open another within two months, aiming for a total of six international centers.